Statement on USG Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern
Life sciences research benefits almost every aspect of our daily lives, leading to improvements in medicine, agriculture, environmental quality, and...
health Journal
Dr. Collins reflects on the challenges in the current budget climate
In an interview with Nature, Dr. Collins discusses the changing landscape of biomedical research. SOURCE: NIH Director's Page - Read...
Dr. Collins at the Economic Club of Washington, D.C.
Topics ranging from genetic sequencing to biomedical research's economic impact. SOURCE: NIH Director's Page - Read entire story here.
NIH Director’s Statement on Dr. Landis’s retirement
Story Landis, Ph.D., will be retiring in the next two months from the directorship of the National Institute of Neurological...
Statement on FDA’s Proposed Oversight of Laboratory-Developed Tests
A statement on the announcement by the Food and Drug Administration (FDA) that it plans to take steps to improve...
Statement Regarding Malaysia Airlines Flight
Numerous researchers, advocates, and public health leaders traveling to International AIDS Conference in Australia on board the Malaysia Airlines flight...
NIH Roadmap/Common Fund at 10
Dr. Collins co-authors a Science Perspective with former NIH director Dr. Elias Zerhouni and NIH’s Dr. Elizabeth Wilder on the...
NIH Director: Recombinant DNA Advisory Committee
Statement by the NIH Director on the IOM report addressing the role of the Recombinant DNA Advisory Committee in oversight...
